SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond.
Lancet Diabetes Endocrinol
Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus; Glucosides; Humans; Kidney; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2
Kidney & Diabetes
Tuttle, Katherine, "SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond." (2021). Articles, Abstracts, and Reports. 4243.